BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
US Department of Justice
Cerilliant
Chubb
Colorcon
Healthtrust
Teva
Novartis
Citi
AstraZeneca

Generated: January 16, 2018

DrugPatentWatch Database Preview

CEFIZOX IN PLASTIC CONTAINER Drug Profile

« Back to Dashboard

When do Cefizox In Plastic Container patents expire, and what generic alternatives are available?

Cefizox In Plastic Container is a drug marketed by Astellas and is included in one NDA.

The generic ingredient in CEFIZOX IN PLASTIC CONTAINER is ceftizoxime sodium. There are five drug master file entries for this compound. Additional details are available on the ceftizoxime sodium profile page.
Drug patent expirations by year for CEFIZOX IN PLASTIC CONTAINER
Medical Subject Heading (MeSH) Categories for CEFIZOX IN PLASTIC CONTAINER

US Patents and Regulatory Information for CEFIZOX IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astellas CEFIZOX IN PLASTIC CONTAINER ceftizoxime sodium INJECTABLE;INJECTION 050589-003 Apr 13, 1995 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Astellas CEFIZOX IN PLASTIC CONTAINER ceftizoxime sodium INJECTABLE;INJECTION 050589-004 Apr 13, 1995 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Farmers Insurance
McKinsey
Healthtrust
Moodys
Merck
Mallinckrodt
Federal Trade Commission
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot